Evidence map›Paper›PMID 34803757›Full record

ArticleFrontiers in psychiatry2021

Psychedelic Experiences During the Early COVID-19 Pandemic: Findings From an International Online Survey.

Ricarda Evens, Simon Reiche, Roman M Marek, Daa Un Moon, Rosa Elisa Groß, Amy Romanello, Dario Jalilzadeh Masah, Matteo Scicchitano Böckheler, Stefan Gutwinski, Christiane Montag and 2 more

Open access · goldAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Frontiers in psychiatry, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed, 1 pooled it
1.6field-weighted citation impact, top 15% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 1 synthesis or guideline pooled it, 16 citations in OpenAlex.

  1. Dose-response relationships of LSD-induced subjective experiences in humans.Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology · 2023
    Pooled it
  2. Observational
  3. Article
  4. Review
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 4 institutions in 1 country.

Ricarda EvensResearch Group Psychotropic Substances, Psychiatric University Clinic at Hospital St. Hedwig | CCM, Charité-Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Berlin, Germany.
Simon ReicheResearch Group Psychotropic Substances, Psychiatric University Clinic at Hospital St. Hedwig | CCM, Charité-Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Berlin, Germany.
Roman M MarekResearch Group Psychotropic Substances, Psychiatric University Clinic at Hospital St. Hedwig | CCM, Charité-Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Berlin, Germany.
Daa Un MoonDepartment of Psychiatry and Neurosciences | CCM, Berlin Institute of Health, Charité-Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Berlin, Germany.
Rosa Elisa GroßDepartment of Psychiatry and Neurosciences | CCM, Berlin Institute of Health, Charité-Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Berlin, Germany.
Amy RomanelloResearch Group Psychotropic Substances, Psychiatric University Clinic at Hospital St. Hedwig | CCM, Charité-Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Berlin, Germany.
Dario Jalilzadeh MasahDepartment of Psychiatry and Neurosciences | CCM, Berlin Institute of Health, Charité-Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Berlin, Germany.
Matteo Scicchitano BöckhelerDepartment of Psychiatry and Neurosciences | CCM, Berlin Institute of Health, Charité-Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Berlin, Germany.
Stefan GutwinskiResearch Group Psychotropic Substances, Psychiatric University Clinic at Hospital St. Hedwig | CCM, Charité-Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Berlin, Germany.
Christiane MontagDepartment of Psychiatry and Neurosciences | CCM, Berlin Institute of Health, Charité-Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Berlin, Germany.
Inge MickResearch Group Psychotropic Substances, Psychiatric University Clinic at Hospital St. Hedwig | CCM, Charité-Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Berlin, Germany.
Tomislav MajićResearch Group Psychotropic Substances, Psychiatric University Clinic at Hospital St. Hedwig | CCM, Charité-Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Berlin, Germany.
Freie Universität Berlin · DEHumboldt-Universität zu Berlin · DECharité - Universitätsmedizin Berlin · DEBerlin-Brandenburg Academy of Sciences and Humanities · DE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

coronadrug useexperiencepandemic (COVID-19)psychedelicSARS-CoV-2settingsurvey

Identifiers

PMID34803757
PMCPMC8599818
OpenAlexW3213088840

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.